Literature DB >> 15019237

Comparisons of envelope through 5B sequences of infectious bronchitis coronaviruses indicates recombination occurs in the envelope and membrane genes.

Judy Elaine Brooks1, Aaron Cameron Rainer, Rebecca Lynn Parr, Peter Woolcock, Fred Hoerr, Ellen Whited Collisson.   

Abstract

A 1.78 kb sequence, including the E, M, 5a and 5b genes, and the intergenic region between the M and 5a genes, of six US strains of infectious bronchitis (corona)virus (IBV) were sequenced and compared to the published sequences for two additional strains. The overall identities as determined through pairwise analyses of nucleotide sequences of the entire 1.78kb region ranged from 90 to 99%, with the 5b open reading frame (ORF) having the greatest identity (94-99%) while the identities of the E, 5a and M ORFs ranged from 87 to 100%. Nucleotide sequencing of recent field isolates from Alabama (Ala1) and California (Cal3) revealed distinct shifts in homology in the M gene, indicating two apparent recombination events between the Holland 52/Mass41-like strain and an Ark-like strain, both origins of commonly used vaccine strains. Putative sites of recombination could also be identified in both the E and M ORFs of laboratory strains of IBV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019237      PMCID: PMC7127682          DOI: 10.1016/j.virusres.2003.11.016

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


Introduction

Infectious bronchitis virus (IBV) is a linear, positive-sense RNA coronavirus that is responsible for recurring economic losses to the poultry industry. First described by Schalk and Hawn (1931) as a “gasping disease” of baby chicks, the clinical signs of IBV infection include respiratory manifestations, such as tracheal rales and coughing, diarrhea, egg loss and nephritis (Beaudette and Hudson, 1937, Winterfield and Hitchner, 1962, Crinion and Hofstad, 1972, Gilchrist, 1963, Cumming, 1963, Julian and Willis, 1969). Different strains of the virus may cause distinct illness. The Gray and Holte strains, for example, have been shown to cause both nephrogenic and respiratory disease (Winterfield and Hitchner, 1962), whereas the Mass41 and Ark99 strains cause primarily respiratory disease (Beaudette and Hudson, 1937, Winterfield and Hitchner, 1962, Cumming, 1963, Darbyshire et al., 1978, Johnson and Marquardt, 1976, Sutou et al., 1988). The pathogenesis and genome arrangement of IBV are similar to the recently described severe acute respiratory syndrome coronavirus or SCoV (Peiris et al., 2003, Drosten et al., 2003, Ksiazek et al., 2003, Marra et al., 2003, Rota et al., 2003). The RNA genome of IBV is about 27.6 kilobases (kb) in length (Boursnell et al., 1987). IBV, like other coronaviruses, has a unique discontinuous transcription which forms a nested set of genomic and subgenomic mRNAs with common 3′ termini with the smaller mRNAs. The 5′ end of each RNA contains the leader sequence found only in the 5′ unique untranslated region of the genome (Spaan et al., 1983; Lai et al., 1984; Stern and Kennedy, 1990a, Stern and Kennedy, 1990b; Gorbalenya, 2001). Due to the economic importance of IBV for much of the last 72 years, an accumulated wealth of genetic IBV variants with distinct serotypes and pathotypes are available. Four major structural proteins make up the virion of IBV and SCoV; the glycosylated spike (S) protein, post-translationally cleaved in IBV but not SCoV, the hydrophobic envelope or small membrane (E) protein, the membrane (M) protein, glycosylated at the amino termini, and the phosphorylated nucleocapsid (N) protein, associated with the viral RNA (Collisson et al., 1992, Cavanagh and Naqi, 1997). A lipid bilayer membrane formed by budding from intracellular membranes surrounds the nucleocapsid. The genome of the Beaudette (Beau) strain of IBV was the first coronavirus genome completely sequenced (Binns et al., 1985; Boursnell et al., 1984, Boursnell et al., 1985a, Boursnell et al., 1985b; Boursnell and Brown, 1984; Brown et al., 1984). The conserved and variable regions of the S and N genes and 3′ untranslated region from a number of US strains of IBV have been identified, as well as potential recombination sites within the S protein (Binns et al., 1986a, Binns et al., 1986b; Niesters et al., 1986a; Boursnell et al., 1985b; Williams et al., 1992, Williams et al., 1993; Wang et al., 1993, Wang et al., 1994; Kwon and Jackwood, 1995; Jia et al., 1995; Gelb et al., 1997; Keeler et al., 1998; Callison et al., 1999; Nix et al., 2000; Kingham et al., 2000). However, comparisons of genomic sequences between the S and N genes on the IBV genome have not been examined with most US strains. Only the nucleotide sequences of the Mass41 (Niesters et al., 1986b, Cavanagh and Davis, 1988, Liu et al., 1991) and Holl52 (Cavanagh and Davis, 1988) E and M genes have been reported. As early as 1988, Cavanagh and Davis postulated that IBV recombination could have occurred between two Dutch strains. Sequence analysis of a portion of the S1 and M genes indicated that one recombinant could have the M gene of one parent strain and the S1 gene of the other (Cavanagh and Davis, 1988, Niesters et al., 1986a). Kusters et al., 1989, Kusters et al., 1990 and Zwaagstra et al. (1992) used phylogenetic trees to illustrate that some strains may have evolved by recombination. Cavanagh et al. (1990) demonstrated that a Portuguese isolate was a recombinant, and that part of the S1 gene of this isolate was very similar to that of the vaccine strain H120. Wang et al. (1993) found evidence of natural recombination in the S1 gene of field isolates of IBV from Texas, concluding that vaccine strains may be involved in recombination of IBV and that recombination occurred in nature. Later studies by Wang et al. (1994) concluded that shifts in homology, as well as point mutations within the S1 gene were common and contribute to the evolution of IBV. Jia et al. (1995) sequenced the isolate CU-T2 and observed recombination events between three different IBV strains within the S2 gene and the N gene with evidence that the Holl52 vaccine strain N contributed to half that gene in CU-T2. Recombination continues to be identified in recent isolates from the United States and Southeast Asia (Lee and Jackwood, 2000a, Lee and Jackwood, 2000b, Lee and Jackwood, 2001; Yu et al., 2001). However, to our knowledge, recombination within the M gene has not been previously reported from a field isolate. This report compares the genomic sequences from the 5′ end of the E gene through the 3′ end of the 5b gene of eight strains of IBV. Six of these were completely sequenced in this region for the first time (Mass41, Iowa, Conn, Arkansas Delmarva Peninsula (Ark DPI), Gray, and Holl52). In addition, the E, M, 5a, and 5b genes of one field isolate from Alabama (Ala1) and most of the M gene of two additional field isolates from California (Cal2 and Cal3) were sequenced and analyzed. Apparent recombinations in the genome of two recent IBV field isolates are described.

Materials and methods

Viral stocks

The Gray strain of IBV was obtained from Dr. R.W. Winterfield at Purdue University, and the Arkansas DPI strain of IBV was obtained from Dr. J.K. Rosenberger at the University of Delaware. Dr. Fred Hoerr kindly provided a field isolate (99 06426 P-3, referred to in this manuscript as Ala1); Dr. Peter Woolcock provided two field isolates used in this study (F9601491, referred to as Cal2, and F9700100, as Cal3).

RT-PCR amplification

Virus was propagated in embryonating chicken eggs (Williams et al., 1992). The protocol described by Burleson et al. (1992) was used to extract RNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed, using the protocol for the SuperScript Preamplification System for First Strand cDNA Synthesis from GibcoBRL (Rockville, MD). Primers were made in the DNA Core Facility, Department of Pathobiology, College of Veterinary Medicine, Texas A&M University (Dr. James Derr, Director, College Station, TX). Table 1 shows the sequences of the primers that were used for PCR amplification and sequencing. In addition, primer D1, complementary to the sequence of the 3′ end of the genome, was used for the RT reactions. A 1–5 μg RNA sample was mixed with 2 mM primer in DEPC-treated water and incubated for 10 min at 70 °C. After a 1 min incubation on ice, the RNA-primer mixtures were mixed with 10× PCR buffer, 25 mM MgCl2, 10 mM dNTP mix, and 0.1 M dithiothreitol (DTT). This mixture was incubated for 5 min at 42 °C. SuperScript II reverse transcriptase (RT) was added to each tube, and this mixture was incubated at 42 °C for 50 min. The reaction was terminated first by incubating at 70 °C for 15 min and then by chilling on ice. RNase H was added, and the reactions were incubated for 20 min at 37 °C. The first strand complementary DNA (cDNA) was either used immediately for PCR amplification or stored at −20 °C.
Table 1

Primers used for PCR amplification of fragments of infectious bronchitis virus to sequence the region from the E gene through the 5b gene

Primer
Sequence
Sense
Position
E1ACTATTGTTATTACAGAGGAPositive24,141–24,160
E2TGCATAGCCATACTGNegative24,613–24,627
M1CTTAACAATCCGGAATTAGAAPositive24,420–24,440
M2TTTCCTAAGAACGGTTGGAATAPositive24,459–24,480
M3ACTCTTTAAGCGGTGTAGGTCPositive24,810–24,830
M4GGCACAAAAGAGTGGAAAAACTGNegative6,479–6,499
M5CTGTCTTTCCAGTTGCCTTACCNegative25,882–25,903
M6TCCCGCGTGTACCTCTCTAGTAPositive25,801–25,822
D1GGATCCGCTCTAACTCTATACTAGCCTANegative27,580–27,608

Primers are written 5’–3’. All primer positions are in relationship to primer locations in the Beaudette genome except primer M4, which is within a deleted region of the Beau genome. The position of primer M4 is relative to the start codon of the S gene of strain KB8523.

Primers used for PCR amplification of fragments of infectious bronchitis virus to sequence the region from the E gene through the 5b gene Primers are written 5’–3’. All primer positions are in relationship to primer locations in the Beaudette genome except primer M4, which is within a deleted region of the Beau genome. The position of primer M4 is relative to the start codon of the S gene of strain KB8523. Target cDNA was amplified by PCR, using the SuperScript Preamplification System for First Strand cDNA Synthesis from GibcoBRL (Rockville, MD). The following reaction was mixed in PCR tubes: 10× PCR buffer, 25 mM MgCl2, 10 mM dNTP mix, 10 mM forward and reverse amplification primers, Taq DNA polymerase, cDNA, and autoclaved, distilled water. PCR amplification was performed at 94 °C for 3 min, then 30 cycles of 95 °C for 1 min, 50 °C for 30 s, and 72  °C for 1 min, followed by a 3 min period at 72 °C. Samples of the PCR products were run on a 1% agarose gel to identify cDNA products.

Nucleotide sequencing

The cDNA samples were purified with the QIAquick PCR Purification Kit from Qiagen (Santa Clarita, CA). PCR products were directly sequenced or were sequenced after cloning into the pCR 2.1 plasmid from the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA). Sequencing was performed using the ABI PRISM dRhodamine Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA). Sequencing PCR reactions were performed for 25 cycles, with 10 s at 96 °C, 5 s at 50 °C, and 4 min at 60 °C. Residual primers were removed from these samples by ethanol precipitation or Bio-Rad Micro Bio-Spin chromatography columns (Hercules, CA). The products of these reactions were sent to the DNA Core Facility, Department of Pathobiology, College of Veterinary Medicine, Texas A&M University (College Station, TX) for dideoxy sequence analysis. Each region was sequenced at least twice from at least two PCR products from different RT reactions.

Computer analysis

Computer analysis of the sequences was performed using the CLUSTLW, SIXFRAME, and DRAWGRAM programs, all from Biology Workbench 5.2 (San Diego Supercomputer Center, University of California, San Diego, CA, 2000). GenBank submissions were made with the BankIt software program through the National Center for Biotechnology Information (NCBI), US National Library of Medicine (Bethesda, MD).

GenBank accession numbers

GenBank accession numbers for the genes submitted through this study included: Gray E, AF318282; Ark DPI E, AF317209; Holl52 E, AF317210; Conn E, AF317471; Iowa E, AF467921; Gray M, AF286180; Mass41 M, AF286184; Ark DPI M, AF286181; Holl52 M, AF286185; Conn M, AF286182; Iowa M, AF286183; Gray intergenic through 5b, AF469011; Mass41 intergenic through 5b, AF469015; Ark DPI intergenic through 5b, AF469012; Holl52 intergenic through 5b, AF469016; Conn intergenic through 5b, AF469013; Iowa intergenic through 5b, AF469014; Alabama 1 E, AF470627; Alabama 1 M, AF470628; Alabama 1 5a and 5b, AF470626; California 2 M, AF470629; California 3 M, AF470630.

Results

The nucleotide sequences of a region extending from the E gene through the 5b gene of six US strains of IBV (Gray, Mass41, Ark DPI, Holl52, Conn, and Iowa) and putative amino acid sequences were determined and compared with each other and the published sequences of the Beaudette (Boursnell et al., 1987) and KB8523 (Sutou et al., 1988) strains. The E, M, 5a, and 5b genes were sequenced for one new field isolate (Ala1). In addition, the M genes of two new field isolates from California were sequenced. This region represented a 1780 nucleotide sequence from the KB8523 strain genome (Sutou et al., 1988), but was shorter in the Beaudette strain (Boursnell et al., 1987) and in the Iowa strain due to lengthy deletions. The remaining five strains had about the same number of nucleotides as the KB8523 strain. The longest sequence of complete conservation was a stretch of 38 identical bases near the 5′ end of the M gene. For each strain examined, the intergenic (IG) consensus sequence CTTAACAA, found at positions 78 through 85 upstream from the start codon of the M gene, positions 9 through 16 upstream from the start codon of the 5a gene, and positions 96 through 103 upstream from the N gene, was identical and in the same positions in the previously published strains.

Pairwise sequence homologies

Pairwise nucleotide sequence homologies in the E gene through 5b region of the various strains ranged from 90 to 99% (data not shown). Overall, the 5b ORF, with 94–99% identity among strains, was the most conserved region and the least conserved E ORF, had 87–99% nucleotide sequence homology. In the 5a gene, the nucleotide sequences of the Ark DPI and Conn strains were 100% identical and 97% identical to those of the Gray strain. The intergenic region between the M gene and the 5a gene was much more variable with an overall identity of only 74%. In addition, the Beaudette strain had a large deletion in this region, and the nucleotide sequences for the Ark DPI, Conn, and Gray strains were 97% identical. Pairwise putative amino acid identities for each individual putative protein ranged from a low of 79% identity for the E, between the Gray and Holl52 strains and between the Conn and Holl52 strains, to 100% identity for M, between the Mass41 and Holl52 strains, and for the 5a gene, between the Conn and Ark DPI strains.

Phylogenetic trees

The sequence relationships of these eight strains of IBV, strain DE072, and the field isolate Ala1 are illustrated in phylogenetic trees for the E, M, 5a, and 5b genes (Fig. 1 ). The trees for all four genes indicated that Gray, Ark DPI, and Conn cluster together. The E gene of the recent Ala1 isolate clustered with Beau, Holl52, and Mass41 (Fig. 1A) and the M gene of Ala1 was also grouped closely with Holl52 (Fig. 1B). However, in the 5a and 5b trees (Fig. 1C and D), Ala1 sequences were placed in a cluster with Conn, Ark DPI, and Gray. The inconsistencies in the clustering observed among the individual trees of each gene suggested shifts in sequencing homology.
Fig. 1

Phylogenetic trees comparing Ala1, DE072, and eight other strains of infectious bronchitis virus. (A) E gene; (B) M gene; (C) 5a gene; (D) 5b gene.

Phylogenetic trees comparing Ala1, DE072, and eight other strains of infectious bronchitis virus. (A) E gene; (B) M gene; (C) 5a gene; (D) 5b gene.

Shifts in homology

Analysis of the region from the E gene through the 3′ end of the 5b region located the shifts in homology or potential recombination sites in the E and M genes (Fig. 2 ), while the remainder of the 1.78 kb sequence did not appear to have any obvious changes in homology. The E genes of the Mass41, Holl52, and Beau strains were very similar in nucleotide sequence (Fig. 2). The Iowa strain was similar to Mass41, Holl52, and Beau for most of the 5′ end and the 3′ end of the E gene, but the middle region was closer to that of the KB8523 strain. The Iowa E gene contained a deletion from bases 276 through 301. The entire E gene of the Ark DPI and Conn strains were very close. The Gray strain E gene was unlike that of the other strains except for three small regions of approximately 50, 80, and 70 nucleotides that were similar to Ark DPI and Conn.
Fig. 2

Shifts in homology in the M gene of infectious bronchitis virus.

Shifts in homology in the M gene of infectious bronchitis virus. The nucleotide sequences of the M gene for Mass41 and Beaudette were clustered together (Fig. 2), whereas the Ark DPI and Conn nucleotide sequences were nearly identical to each other. Although the 5′ end of the Gray M gene differed from the other strains, the 3′ end was quite similar to that of Ark DPI and Conn and in contrast, the 5′ end of Holl52 was similar to that of Mass41, KB8523, and Beau, while the 3′ end differed from all the other strains. The middle regions of the M represented shifts in homology or potential recombination in the Gray and KB8523. Putative sites of recombination were also identified at the 3′ end of the Iowa strain M gene. Only 46% of the 5′ 50 bases of the M gene were conserved. This region encodes the amino acids of M that lie external to the virion envelope.

Analysis of field isolates

When the E, M, 5a, and 5b genes for the 1999 Ala1 isolate were sequenced and compared with the other genomes (Table 2 ), shifts in homology were obvious. The nucleotide sequence of the E gene of this isolate was similar to those of Mass41, Holl52, and Beau. The M gene appeared to have originated from at least two distinct parental strains (Fig. 2). The first approximately 75 base sequence of the Ala1 M gene was similar to Mass41, Holl52, KB8523, and Beau, but from nucleotide 80 through 140 was identical to the M sequences of Ark DPI and Conn. A region of approximately 600 nucleotides from nucleotide 150 to the 3′ end and into the intergenic region downstream of the M, was nearly identical with Holl52. However, the 5a gene and most of the 5b gene for Ala1 were again identical to Conn and Ark DPI. These comparisons with the Ala1 sequences identified two apparent recombination events within the M gene. The first recombination occurred between nucleotide 60 and nucleotide 70 of the M gene, shifting from a Mass41, Holl52, KB8523, or Beau-like sequence to a sequence perfectly identical to Ark DPI and Conn. Another apparent recombination event occurred between nucleotide 150 and nucleotide 215 of the M gene and thereafter, the Ala1 nucleotide sequence most closely resembled the Holl52 strain.
Table 2

Percentage identities of sequences within the M genes of Ala1 and Cal3

Nucleotide location
ArkDPI
Mass41
Holl52
Ala1
 1–606410098
 61–215999089
 216–678949599


Cal3






 1–59699391
 60–225969089
 226–600919393
Percentage identities of sequences within the M genes of Ala1 and Cal3 Wang et al. (1993) noted that the sequence CTT(A/T)(A/T)G was located near every putative junction where homology shifts were found. The sequence CTTTTG was identified between bases 171 and 176 of the M gene (Fig. 3 ). This site is in the middle of a 60-nucleotide region of 100% identity, including the Ala1 isolate. In addition, the second apparent recombination event in the Ala1 isolate occurred within this region of total homology. The nucleotide sequences of the 5a and 5b genes for Ala1 were 99% identical to those of Conn and Ark DPI and only 93 and 96% identical to the respective genes for Holl52, indicating that another recombination event may have occurred within the intergenic region between the M gene and the 5a gene.
Fig. 3

Nucleotide sequences of the M gene of Ark DPI, Holl52, Alabama 1 (Ala1), and California 3 (Cal3).

Nucleotide sequences of the M gene of Ark DPI, Holl52, Alabama 1 (Ala1), and California 3 (Cal3). Overall, the nucleotide sequence of the M for the recent isolate Cal2 was similar to that of the Gray strain (data not shown). However, the Cal3 isolate had putative sites of recombination in the M gene. From nucleotide 170 of the E gene through nucleotide 50 of the M gene, the Cal3 nucleotide sequence was similar to that of the Mass41, Holl52, KB8523, and Beau group. However, from approximately nucleotide 60 of the M gene through 250 of the M gene, the Cal3 sequence was similar to that of Ark DPI. From about 250 the Cal3 then resembled the M gene of Mass41 and Beau. Thus, Cal3 had two apparent recombination events within the M gene.

Discussion

This is the first report of nucleotide sequence comparisons, representing the E through the 5b region of the IBV genome. The comparisons of sequences from eight strains of IBV showed abrupt shifts in homology that suggested recombination had occurred in several locations within this region. Williams et al., 1992, Williams et al., 1993 analyzed the nucleocapsid gene sequences and the 3′ non-coding regions and found that the five strains that they analyzed (Mass41, Beaudette, KB8523, Ark99, and Gray strains) had a percent nucleotide identity ranging from 93.2 (between the Ark99 and KB8523 strains) to 99.1 (between the Beaudette and Mass41 strains) for the 3′ non-coding region. The similarities of the amino acid sequences of the nucleocapsid proteins of those five strains ranged from 90.7 to 96.3% and the Gray strain showed the least overall similarity to the other strains. Wang et al. (1994) produced a phylogenetic tree that showed the relationships of 25 different IBV strains and field isolates based on their S1 amino acid sequences. These were divided into five genotypic groups based on the homologies among the strains. The Iowa 609 and Gray strains were in one group; the KB8523, H52, Beaudette, Mass41, and Conn strains were in another; Ark99 strain was in still another group. Like the Williams et al., 1992, Williams et al., 1993 studies of the nucleocapsid and 3′ UTR sequences, the phylogenetic trees of the genes of the 1.78 kb region clustered Gray and Ark at one end of the tree, while Beau, Holl52, and Mass41 were placed at the other end. Wang et al. (1994), however, found that the S1 genes of the Iowa and Gray strains were clustered together and the Ark99 strain was in another group. As with the present study and the Williams et al., 1992, Williams et al., 1993 studies, Wang et al. (1994) noted that the S1 gene of Beau, Holl52, and Mass41 formed a common group. Combined with the present work, these results indicated a homology shift for the Ark, Gray, and Iowa strains somewhere in the region between the S1 gene and the E gene. Moreover, the phylogenetic trees in this study suggested that putative recombination occurred to generate the recently isolated Ala1 strain. The tree for the E gene placed Ala1 in a cluster with Beau and Mass41. In the M gene, Ala1 was grouped with Holl52, whereas in the 5a and 5b genes, Ala1 was close to Conn, Ark DPI, and Gray. It has been postulated that the intergenic (IG) consensus sequences CTTAACAA or CTGAACAA and the conserved region around these sequences may be “hot spots” for recombination (Jia et al., 1995, Lee and Jackwood, 2000b). In the present study, no recombination “hot spots” were found at the IG consensus sequences (CTTAACAA). The sequence CTTTTG, that Wang et al. (1993) described adjacent to every putative recombination junction, was found twice within the M gene and once within the 5b gene for every strain studied in this paper. In addition, this sequence was found once within the E gene, once within the intergenic region between the M and 5a genes, and once within the 5a gene for several of the strains. Data from the present study demonstrated one putative recombination site in the M gene of the Ala1 isolate that was 40 nucleotides downstream from the first CTTTTG sequence in the M gene. These so-called “hot spots” could possibly promote recombination because they are A-T-rich regions. However, recombination events among the eight strains would seem to occur randomly rather than at specific “hot spots”, because only one apparent recombination occurred near the CTTTTG sequence. Whereas there were no detectable recombination events in the 5a or 5b genes, the nucleotide sequence of the 5b gene is well conserved. Sequencing of field isolates demonstrated recombination within the M gene. A recombination sequence could be identified as related to a portion of the Holl52 vaccine. Such natural recombination is apparently a widespread event and occurs throughout the genome, providing a natural process for the construction of genetic variants that produce more virulent strains of IBV.
  48 in total

Review 1.  Big nidovirus genome. When count and order of domains matter.

Authors:  A E Gorbalenya
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Comparison of the spike precursor sequences of coronavirus IBV strains M41 and 6/82 with that of IBV Beaudette.

Authors:  M M Binns; M E Boursnell; F M Tomley; D K Brown
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

3.  Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus.

Authors:  M E Boursnell; T D Brown; I J Foulds; P F Green; F M Tomley; M M Binns
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

4.  Infectious bronchitis virus S2 gene sequence variability may affect S1 subunit specific antibody binding.

Authors:  S A Callison; M W Jackwood; D A Hilt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Antigenic and S-1 genomic characterization of the Delaware variant serotype of infectious bronchitis virus.

Authors:  J Gelb; C L Keeler; W A Nix; J K Rosenberger; S S Cloud
Journal:  Avian Dis       Date:  1997 Jul-Sep       Impact factor: 1.577

6.  Molecular epidemiology of infectious bronchitis virus isolates from China and Southeast Asia.

Authors:  L Yu; Z Wang; Y Jiang; S Low; J Kwang
Journal:  Avian Dis       Date:  2001 Jan-Mar       Impact factor: 1.577

7.  Serotype identification of avian infectious bronchitis virus by RT-PCR of the peplomer (S-1) gene.

Authors:  C L Keeler; K L Reed; W A Nix; J Gelb
Journal:  Avian Dis       Date:  1998 Apr-Jun       Impact factor: 1.577

8.  Evolution of avian coronavirus IBV: sequence of the matrix glycoprotein gene and intergenic region of several serotypes.

Authors:  D Cavanagh; P J Davis
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

9.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

10.  Comparative analyses of the nucleocapsid genes of several strains of infectious bronchitis virus and other coronaviruses.

Authors:  A K Williams; L Wang; L W Sneed; E W Collisson
Journal:  Virus Res       Date:  1992-09-15       Impact factor: 3.303

View more
  18 in total

1.  Sequence and phylogenetic analysis of S1, S2, M, and N genes of infectious bronchitis virus isolates from Malaysia.

Authors:  Zarirah M Zulperi; A R Omar; S S Arshad
Journal:  Virus Genes       Date:  2009-02-26       Impact factor: 2.332

2.  Sequencing, phylogenetic analysis, and potential recombination events of infectious bronchitis viruses isolated in Korea.

Authors:  Jae Eun Song; Won Gu Jeong; Haan Woo Sung; Hyuk Moo Kwon
Journal:  Virus Genes       Date:  2012-12-01       Impact factor: 2.332

3.  Genetic diversity of spike, 3a, 3b and e genes of infectious bronchitis viruses and emergence of new recombinants in Korea.

Authors:  Mei-Lan Mo; Seung-Min Hong; Hyuk-Joon Kwon; Il-Hwan Kim; Chang-Seon Song; Jae-Hong Kim
Journal:  Viruses       Date:  2013-01-31       Impact factor: 5.048

4.  Genome Organization of Canada Goose Coronavirus, A Novel Species Identified in a Mass Die-off of Canada Geese.

Authors:  Amber Papineau; Yohannes Berhane; Todd N Wylie; Kristine M Wylie; Samuel Sharpe; Oliver Lung
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

5.  Complete genome sequence and recombination analysis of infectious bronchitis virus attenuated vaccine strain H120.

Authors:  Yi Zhang; Hong-Ning Wang; Ting Wang; Wen-Qiao Fan; An-Yun Zhang; Kun Wei; Guo-Bao Tian; Xin Yang
Journal:  Virus Genes       Date:  2010-07-23       Impact factor: 2.332

Review 6.  Molecular evolution and emergence of avian gammacoronaviruses.

Authors:  Mark W Jackwood; David Hall; Andreas Handel
Journal:  Infect Genet Evol       Date:  2012-05-17       Impact factor: 3.342

7.  In vitro assembled, recombinant infectious bronchitis viruses demonstrate that the 5a open reading frame is not essential for replication.

Authors:  Soonjeon Youn; Julian L Leibowitz; Ellen W Collisson
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

8.  Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus.

Authors:  Enid T McKinley; Mark W Jackwood; Deborah A Hilt; Jessica C Kissinger; Jon S Robertson; Cornelia Lemke; Andrew H Paterson
Journal:  Virus Res       Date:  2011-04-22       Impact factor: 3.303

9.  Comparative genomics of Korean infectious bronchitis viruses (IBVs) and an animal model to evaluate pathogenicity of IBVs to the reproductive organs.

Authors:  Seung-Min Hong; Hyuk-Joon Kwon; Il-Hwan Kim; Mei-Lan Mo; Jae-Hong Kim
Journal:  Viruses       Date:  2012-10-30       Impact factor: 5.048

10.  Identification of Taiwan and China-like recombinant avian infectious bronchitis viruses in Taiwan.

Authors:  Hui-Wen Chen; Yuan-Pin Huang; Ching-Ho Wang
Journal:  Virus Res       Date:  2009-01-20       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.